Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eija Nissilä

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Biomolecules|June 28, 2014
Oxysterols and their cellular effectorsVesa M Olkkonen, Olivier Béaslas, Eija Nissilä
Microbiology Spectrum|July 7, 2025
The total gut mucosal and fecal bacterial load increases in successful treatment of inflammatory bowel disease with infliximabRebecka Ventin-Holmberg, Julia Eriksson, Anja Eberl, et al.
Biochimica Et Biophysica Acta|August 22, 2012
ORP10, a cholesterol binding protein associated with microtubules, regulates apolipoprotein B-100 secretionEija Nissilä, Yuki Ohsaki, Marion Weber-Boyvat, et al.
Journal of Crohn'S & Colitis|December 10, 2020
Bacterial and Fungal Profiles as Markers of Infliximab Drug Response in Inflammatory Bowel DiseaseRebecka Ventin-Holmberg, Anja Eberl, Schahzad Saqib, et al.
Inflammatory Bowel Diseases|August 30, 2022
Quantitative Fecal Microbiota Profiles Relate to Therapy Response During Induction With Tumor Necrosis Factor α Antagonist Infliximab in Pediatric Inflammatory Bowel DiseaseMiikka Höyhtyä, Katri Korpela, Schahzad Saqib, et al.
Plos One|July 13, 2017
Correction: Genotypic and phenotypic diversity of Lactobacillus rhamnosus clinical isolates, their comparison with strain GG and their recognition by complement systemEija Nissilä, François P Douillard, Jarmo Ritari, et al.
Plos One|May 12, 2017
Genotypic and phenotypic diversity of Lactobacillus rhamnosus clinical isolates, their comparison with strain GG and their recognition by complement systemEija Nissilä, François P Douillard, Jarmo Ritari, et al.
Scandinavian Journal of Immunology|January 31, 2025
The COVID-19 vaccine ChAdOx1 is opsonized by anti-vector antibodies that activate complement and promote viral vector phagocytosisEija Nissilä, Leo Starck, Elias Aho, et al.
Plos One|April 5, 2013
Osbpl8 deficiency in mouse causes an elevation of high-density lipoproteins and gender-specific alterations of lipid metabolismOlivier Béaslas, Jari Metso, Eija Nissilä, et al.
The Journal of Biological Chemistry|October 16, 2015
Complement Factor H Binds to Human Serum Apolipoprotein E and Mediates Complement Regulation on High Density Lipoprotein ParticlesKarita Haapasalo, Kok van Kessel, Eija Nissilä, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Biomolecules|June 28, 2014
Oxysterols and their cellular effectorsVesa M Olkkonen, Olivier Béaslas, Eija Nissilä
Microbiology Spectrum|July 7, 2025
The total gut mucosal and fecal bacterial load increases in successful treatment of inflammatory bowel disease with infliximabRebecka Ventin-Holmberg, Julia Eriksson, Anja Eberl, et al.
Biochimica Et Biophysica Acta|August 22, 2012
ORP10, a cholesterol binding protein associated with microtubules, regulates apolipoprotein B-100 secretionEija Nissilä, Yuki Ohsaki, Marion Weber-Boyvat, et al.
Journal of Crohn'S & Colitis|December 10, 2020
Bacterial and Fungal Profiles as Markers of Infliximab Drug Response in Inflammatory Bowel DiseaseRebecka Ventin-Holmberg, Anja Eberl, Schahzad Saqib, et al.
Inflammatory Bowel Diseases|August 30, 2022
Quantitative Fecal Microbiota Profiles Relate to Therapy Response During Induction With Tumor Necrosis Factor α Antagonist Infliximab in Pediatric Inflammatory Bowel DiseaseMiikka Höyhtyä, Katri Korpela, Schahzad Saqib, et al.
Plos One|July 13, 2017
Correction: Genotypic and phenotypic diversity of Lactobacillus rhamnosus clinical isolates, their comparison with strain GG and their recognition by complement systemEija Nissilä, François P Douillard, Jarmo Ritari, et al.
Plos One|May 12, 2017
Genotypic and phenotypic diversity of Lactobacillus rhamnosus clinical isolates, their comparison with strain GG and their recognition by complement systemEija Nissilä, François P Douillard, Jarmo Ritari, et al.
Scandinavian Journal of Immunology|January 31, 2025
The COVID-19 vaccine ChAdOx1 is opsonized by anti-vector antibodies that activate complement and promote viral vector phagocytosisEija Nissilä, Leo Starck, Elias Aho, et al.
Plos One|April 5, 2013
Osbpl8 deficiency in mouse causes an elevation of high-density lipoproteins and gender-specific alterations of lipid metabolismOlivier Béaslas, Jari Metso, Eija Nissilä, et al.
The Journal of Biological Chemistry|October 16, 2015
Complement Factor H Binds to Human Serum Apolipoprotein E and Mediates Complement Regulation on High Density Lipoprotein ParticlesKarita Haapasalo, Kok van Kessel, Eija Nissilä, et al.
Pageof 2